Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comparison of two methods of administering bronchodilator aerosol to asthmatic patients.

Literature DB >> 1092420

Comparison of two methods of administering bronchodilator aerosol to asthmatic patients.

Abstract

In 78 patients with chronic asthma the increase in forced expiratory volume in one second (FEV-1) after the administration by intermittent positive-pressure ventilation (I.P.P.V.) of 10 mg of salbutamol was compared with that recorded after the inhalation of a conventional dose (200 mug) from a pressurized canister. The mean increase was significantly greater after I.P.P.V. administration, and the superiority of this method was greatest in patients with the lowest pretreatment FEV-1.

Entities: Chemical Disease Species

Mesh：

Substances：
Aerosols
Albuterol

Year: 1975 PMID： 1092420 PMCID： PMC1673124 DOI： 10.1136/bmj.2.5963.119

Source DB: PubMed Journal: Br Med J ISSN： 0007-1447

6 in total

1. COMPARATIVE EFFECTS OF ISOPROTERENOL AEROSOLS ON AIRWAY RESISTANCE IN OBSTRUCTIVE PULMONARY DISEASES.

Authors: A A COHEN; F C HALE
Journal: Am J Med Sci Date: 1965-03 Impact factor: 2.378

2. Forced expiratory volume before and after isoprenaline.

Authors: K M HUME; B GANDEVIA
Journal: Thorax Date: 1957-09 Impact factor: 9.139

3. Salbutamol by intermittent positive pressure ventilation in status asthmaticus.

Authors: Y F Choo-Kang; A E Tribe; I W Grant
Journal: Scott Med J Date: 1974-07 Impact factor: 0.729

4. Rise and fall of asthma mortality in England and Wales in relation to use of pressurised aerosols.

Authors: W H Inman; A M Adelstein
Journal: Lancet Date: 1969-08-09 Impact factor: 79.321

5. Asthma mortality. Why the United States was spared an epidemic of deaths due to asthma.

Authors: P D Stolley
Journal: Am Rev Respir Dis Date: 1972-06

6. The fate of nebulized salbutamol (albuterol) administered by intermittent positive pressure respiration to asthmatic patients.

Authors: G M Shenfield; M E Evans; S R Walker; J W Paterson
Journal: Am Rev Respir Dis Date: 1973-09

6 in total

12 in total

1. Clinical practice guidelines for the use of noninvasive positive-pressure ventilation and noninvasive continuous positive airway pressure in the acute care setting.

Authors: Sean P Keenan; Tasnim Sinuff; Karen E A Burns; John Muscedere; Jim Kutsogiannis; Sangeeta Mehta; Deborah J Cook; Najib Ayas; Neill K J Adhikari; Lori Hand; Damon C Scales; Rose Pagnotta; Lynda Lazosky; Graeme Rocker; Sandra Dial; Kevin Laupland; Kevin Sanders; Peter Dodek
Journal: CMAJ Date: 2011-02-14 Impact factor: 8.262

2. Aerosol salbutamol administration by IPPB: lowest effective dose.

Authors: R E Ruffin; G Obminski; M T Newhouse
Journal: Thorax Date: 1978-12 Impact factor: 9.139

3. The metabolic effects of inhaled salbutamol.

Authors: S M Bateman; J Pidgeon; S G Spiro; A J Johnson
Journal: Br J Clin Pharmacol Date: 1978-02 Impact factor: 4.335

4. Nebulised fenoterol compared with metered aerosol.

Authors: C Melville; P D Phelan; L I Landau
Journal: Arch Dis Child Date: 1985-03 Impact factor: 3.791

5. Comparison of three techniques of inhalation on the airway response to terbutaline.

Authors: M J Cushley; R A Lewis; A E Tattersfield
Journal: Thorax Date: 1983-12 Impact factor: 9.139

6. Comparison of salbutamol given by intermittent positive-pressure breathing and pressure-packed aerosol in chronic asthma.

Authors: P B Anderson; A Goude; M D Peake
Journal: Thorax Date: 1982-08 Impact factor: 9.139